Cerebrospinal fluid from frontotemporal dementia patients is toxic to neurons.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 21 01 2021
revised: 02 03 2021
accepted: 04 03 2021
pubmed: 14 3 2021
medline: 11 9 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

Frontotemporal Lobar Degeneration (FTD) is a neurodegenerative disease characterized by a progressive deterioration of cognitive functions. Currently, no effective treatment exists. We have studied cytotoxicity and neuronal functionality in cortical and spinal cord cultures upon exposure to cerebrospinal fluid (CSF) from 39 FTD patients. FTD-CSF alters the miniature excitatory postsynaptic currents in the cortical cultures and it is toxic to spinal cord cultures, particularly to GABAergic+ and calbindin-D28k + neurons.

Identifiants

pubmed: 33713790
pii: S0925-4439(21)00055-7
doi: 10.1016/j.bbadis.2021.166122
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

166122

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alida Spalloni (A)

Department of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Rome, Italy.

Silvia Caioli (S)

Department of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Rome, Italy.

Elisa Bonomi (E)

Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Cristina Zona (C)

Department of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Rome, Italy.

Emanuele Buratti (E)

International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

Antonella Alberici (A)

Centre for Neurodegenerative Disorders, Neurology Unit, Spedali Civili Hospital Brescia, Italy.

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Patrizia Longone (P)

Department of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Rome, Italy. Electronic address: p.longone@hsantalucia.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH